The seed of Universal Diagnostics (UDX) was born at NASA Ames Park, in Mountain View, California, during the summer of 2012. Following SingularityUniversity’s global challenge to impact positively one billion people, two experienced technology entrepreneurs decided to launch together a bio-medicine start-up with the goal of fighting Humanity’s most important enemy: cancer.
The company was officially incorporated in Spain.
The monumental goal of UDX is to develop a test to detect cancer early, when it still can be cured and save millions of lives.
The company closed a seed round of capital from international investors.
UDX started a large-scale research metabolomics project for discovering ex-novo biomarkers for different cancers with high incidence and mortality rate in the world.
UDX established alliances and collaborations with international universities, biobanks and hospitals to validate the technology in all races and populations.
UDX opened its US headquarters in Silicon Valley (JLabs South San Francisco).
MEDy Award Winner to “the Most Disruptive Start-up” at Exponential Medicine, a top healthcare conference by Singularity University (NASA Ames Park).
Launch of clinical studies in multiple international hospitals, development of quality management system to get the regulatory approvals to launch the first product in main global markets: a blood-based test for the early detection of colorectal cancer and polyps.
Team of 25 people.
Founder and CEO
Founder and CTO